← Eichor
Study identifier: NCT07361510 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Condition: Non-Small Cell Lung Cancer (NSCLC)  ·  Sponsor: Bristol-Myers Squibb

PhasePhase 3
Planned participants750
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%.

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com  ·  855-907-3286  ·  Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (274)

Southern Cancer Center PcDaphne, Alabama, United StatesRecruiting
Mohtaseb Cancer Center & Blood DisordersBullhead City, Arizona, United StatesRecruiting
Palo Verde Hematology OncologyGlendale, Arizona, United StatesRecruiting
Local Institution - 0407Anaheim, California, United StatesNot Yet Recruiting
Local Institution - 0352Beverly Hills, California, United StatesNot Yet Recruiting
Orange Coast Memorial Medical CenterFountain Valley, California, United StatesRecruiting
Local Institution - 0027Los Alamitos, California, United StatesNot Yet Recruiting
Local Institution - 0422Los Angeles, California, United StatesNot Yet Recruiting
Local Institution - 0403Oakland, California, United StatesNot Yet Recruiting
Local Institution - 0208Pleasant Hill, California, United StatesNot Yet Recruiting
Local Institution - 0416Walnut Creek, California, United StatesNot Yet Recruiting
Local Institution - 0340Lakewood, Colorado, United StatesNot Yet Recruiting

+ 262 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07361510